KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 150 filers reported holding KURA ONCOLOGY INC in Q2 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $558,486 | +56.2% | 52,787 | +80.5% | 0.26% | -12.0% |
| Q1 2023 | $357,630 | -82.4% | 29,242 | -82.2% | 0.29% | -75.9% |
| Q4 2022 | $2,036,642 | -24.7% | 164,113 | -17.1% | 1.21% | -21.8% |
| Q3 2022 | $2,706,000 | -32.2% | 198,076 | -9.1% | 1.55% | -35.9% |
| Q2 2022 | $3,994,000 | +68.0% | 217,895 | +47.4% | 2.41% | +59.6% |
| Q1 2022 | $2,377,000 | +106.7% | 147,833 | +80.0% | 1.51% | +65.0% |
| Q4 2021 | $1,150,000 | -13.4% | 82,124 | +15.9% | 0.92% | +4.2% |
| Q3 2021 | $1,328,000 | +65.8% | 70,888 | +84.5% | 0.88% | +54.8% |
| Q2 2021 | $801,000 | -6.2% | 38,428 | +27.2% | 0.57% | -10.6% |
| Q1 2021 | $854,000 | +5.8% | 30,212 | +22.3% | 0.64% | +23.3% |
| Q4 2020 | $807,000 | +6.0% | 24,708 | -0.5% | 0.52% | -7.2% |
| Q3 2020 | $761,000 | +56.9% | 24,833 | -16.5% | 0.56% | +38.1% |
| Q2 2020 | $485,000 | – | 29,741 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 3,766,852 | $57,633,000 | 6.49% |
| GREAT POINT PARTNERS LLC | 2,197,283 | $33,618,000 | 5.74% |
| Sio Capital Management, LLC | 392,027 | $5,998,000 | 3.38% |
| BVF INC/IL | 1,353,846 | $20,714,000 | 2.50% |
| Boxer Capital, LLC | 844,789 | $12,925,000 | 2.36% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 89,673 | $1,372,000 | 2.18% |
| Minerva Advisors LLC | 170,921 | $2,607,000 | 1.41% |
| NEXTHERA CAPITAL LP | 445,550 | $6,817,000 | 1.26% |
| DAFNA Capital Management LLC | 117,281 | $1,794,000 | 0.97% |
| PFM Health Sciences, LP | 1,752,124 | $26,807,000 | 0.64% |